Fertility Preservation Before Cancer Treatment: What You Should Know
- Dr. Omid Modiramani, MD
- Apr 11
- 3 min read
Updated: Apr 16

Why Early Discussion for Fertility Matters ?
A cancer diagnosis requires urgent and complex decision-making. While the primary focus is often on survival and treatment efficacy, future fertility is an essential aspect of long-term survivorship that should not be overlooked.
Fertility preservation prior to cancer treatment represents a critical step for patients who wish to maintain the possibility of having children in the future. Early discussion and timely intervention can significantly improve reproductive outcomes and quality of life after treatment.
What Do International Guidelines Say about fertility preservation before cancer treatment ?
Leading organizations including the American Society of Clinical Oncology, European Society for Medical Oncology, National Comprehensive Cancer Network, and American Society for Reproductive Medicine strongly recommend:
✔ Early discussion of infertility risks
✔ Referral to fertility specialists before treatment
✔ Offering fertility preservation to all eligible patients
👉 Importantly, these recommendations apply to both men and women of reproductive age.
Mechanisms of Treatment-Related Infertility
Cancer therapies may impair fertility through direct gonadal toxicity or disruption of the hypothalamic–pituitary–gonadal axis.
High-risk treatments include:
Chemotherapy (especially alkylating agents causing ovarian/testicular failure)
Radiation therapy (dose-dependent gonadal damage, particularly pelvic irradiation)
Surgical resection of reproductive organs
Hematopoietic stem cell transplantation, often associated with high-dose conditioning regimens
📌 The degree of damage depends on age, baseline ovarian reserve, cumulative dose, and treatment type.
Evidence-Based Fertility Preservation Options
For Women
✔ Oocyte Cryopreservation (Egg Freezing)
No partner required
High success rates with modern vitrification
✔ Embryo Cryopreservation
Long-established with robust outcomes
Requires sperm source
✔ Ovarian Tissue Cryopreservation
Now considered non-experimental by ASRM
Particularly useful when urgent treatment is required
For Men
✔ Sperm Cryopreservation
Standard of care across all major guidelines (ASCO, NCCN)
Rapid, accessible, and highly effective
⏱️ Timing: A Critical Window
All major guidelines — including ASCO and NCCN — emphasize:
👉 Fertility preservation should be addressed before initiation of systemic therapy
Even a short delay (typically 1–2 weeks) can allow:
Controlled ovarian stimulation
Sperm collection
Multidisciplinary planning
Discussing fertility preservation early... before cancer treatment early can help patients access more options
Gaps in Real-World Practice
Despite clear guideline recommendations, studies show that a significant proportion of patients are not counseled about fertility risks in a timely manner.
This represents a major gap in quality cancer care.
Clinical Implications
You should proactively discuss fertility preservation if:
The patient is of reproductive age
Future childbearing is a consideration
Gonadotoxic therapy is planned
👉 Early counseling allows informed, patient-centered decision-making without compromising oncologic outcomes.
Role of Second Opinion in Fertility-Sensitive Cases
A second opinion can help:
Stratify individual infertility risk based on treatment plan
Identify guideline-supported preservation strategies
Coordinate timing without delaying cancer therapy
Provide clear, evidence-based recommendations aligned with recent international Guideline standards
Take Action Before Treatment Starts
Fertility preservation is time-sensitive but often feasible.
👉 Missing this window may lead to irreversible loss of reproductive potential.
If you need clarity before starting treatment:
References
American Society for Reproductive Medicine. Fertility preservation in patients with medical indications: Committee Opinion. 2026.
JAMA. Castillo J, Davis AM, Burns KC. Fertility Preservation in People With Cancer. Published online February 2026.
American Society for Reproductive Medicine. Fertility preservation in patients with medical indications: Committee Opinion. 2026.
Medical Oncologist & Hematologist
If you would like an expert, evidence-based cancer second opinion online, you can request a comprehensive review
For inquiries: info@iconsecondopinion.com
_edited_edited.png)


Comments